In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study evaluating NS002, its investigational intranasal epinephrine powder for ...
The dust has settled after the whirlwind start of NFL free agency, with the league's landscape looking drastically different ...
HOUSTON, TX / ACCESS Newswire / March 19, 2026 / EON Resources Inc. (NYSE American:EONR) ("EON" or the "Company") is an independent upstream energy company with 20,000 leasehold acres in the Permian ...
Full year 2025 Highlights Achieved full-year production guidance with 34,098 gold-equivalent ounces produced in calendar 2025 Outperformed calendar 2025 cash cost guidance with consolidated cash costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results